Evaluation of process indicators of a medication review service between pharmacists and physicians

Rationale, aims and objectives Literature have showed inconclusive or contradictory results regarding medication review services effectiveness in optimizing process indicators. Thus, this study aimed to evaluate the process indicators of a medication review service between pharmacists and physicians...

Full description

Saved in:
Bibliographic Details
Published in:Journal of evaluation in clinical practice 2020-10, Vol.26 (5), p.1448-1456
Main Authors: Marques, Tatiane C., Silva, Rafaella de Oliveira Santos, Santos Júnior, Genival A., Jesus Júnior, Francisco C., Silvestre, Carina C., Rocha, Kérilin S. S., Rocha, Chiara E., Brito, Giselle de Carvalho, Lyra‐Jr, Divaldo P.
Format: Article
Language:English
Subjects:
Collaboration
Initiatives
medication review
pharmaceutical intervention
Pharmaceuticals
Pharmacists
pharmacist‐physician collaboration
Physicians
Prescriptions
process indicators
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale, aims and objectives Literature have showed inconclusive or contradictory results regarding medication review services effectiveness in optimizing process indicators. Thus, this study aimed to evaluate the process indicators of a medication review service between pharmacists and physicians. Method This quasi‐experimental study was conducted between March 2013 and February 2014 with patients who were receiving care in a medication review service in a teaching hospital in northeastern Brazil. The main process indicators were number of pharmaceutical consultations; identification and resolution of drug‐related problems (DRP) and pharmaceutical interventions that were classified according to type and degree of acceptance. Descriptive statistics were used to report data. The statistical significance of the association between variables was evaluated using the Mantel‐Haenszel chi‐square test. The 95% confidence interval was considered, and differences were deemed statistically significant if P ≤ .05. Results A total of 146 patients attended the medication review service. The number of consultations per patient ranged from one to five (2.1 ± 1.1). The service identified 366 DRP, most of which were indication (67.5%). Patients who had four to five pharmaceutical consultations were 1.14 times more likely to have their DRP identified (χ2 = 33.83, P 
ISSN:1356-1294
1365-2753
DOI:10.1111/jep.13332